Cargando…
Role of tocilizumab for concomitant systemic fungal infection in severe COVID-19 patient: Case report
RATIONALE: Bacterial and fungal infections in Coronavirus Disease-19 (COVID-19) patients have been inadequately investigated and reported thus far. The safety profile of tocilizumab (TCZ) administration in candidemia patient still debatable. PATIENT CONCERNS: A 54 year-old woman presenting with weak...
Autores principales: | Sari, Anggraini Permata, Darnindro, Nikko, Yohanes, Aryan, Mokoagow, Muhammad Ikhsan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282040/ https://www.ncbi.nlm.nih.gov/pubmed/33761696 http://dx.doi.org/10.1097/MD.0000000000025173 |
Ejemplares similares
-
The role of early blood purification for miliary tuberculosis presenting as acute respiratory distress syndrome in pregnancy: A case report
por: Sari, Anggraini Permata, et al.
Publicado: (2023) -
No evidence of tocilizumab treatment efficacy for severe to critical SARS-CoV2 infected patients: Results from a retrospective controlled multicenter study
por: Burlacu, Ruxandra, et al.
Publicado: (2021) -
Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission
por: Sánchez-Rovira, Pedro, et al.
Publicado: (2021) -
Off-label tocilizumab and adjuvant iron chelator effectiveness in a group of severe COVID-19 pneumonia patients: A single center experience
por: Birlutiu, Victoria, et al.
Publicado: (2021) -
Effectiveness of tocilizumab in the treatment of hospitalized adults COVID-19: A systematic review and meta-analysis
por: Zhang, Jing, et al.
Publicado: (2022)